Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of anti-cancer drugs. The main symptoms often include sensory disturbances and neuropathic pain, and currently there is no effective treatment for this condition. This study aimed to investigate the suppressive effects of magnolin, an extracellular signal-regulated kinase (ERK) inhibitor substance derived from a 95% EtOH extract of the seeds of Magnolia denudata, on the symptoms of CIPN. A taxol-based anti-cancer drug paclitaxel (PTX) was repeatedly injected (2 mg/kg/day, total 8 mg/kg) into mice to induce CIPN. A neuropathic pain symptom was assessed using a cold allodynia test that scores behaviors of licking and shaking paw after plantar administration of acetone drop. Magnolin was administered intraperitoneally (0.1, 1, or 10 mg/kg) and behavioral changes to acetone drop were measured. The effect of magnolin administration on ERK expression in the dorsal root ganglion (DRG) was investigated using western blot analysis. The results showed that the repeated injections of PTX induced cold allodynia in mice. Magnolin administration exerted an analgesic effect on the PTX-induced cold allodynia and inhibited the ERK phosphorylation in the DRG. These results suggest that magnolin could be developed as an alternative treatment to suppress paclitaxel-induced neuropathic pain symptoms.
Original language | English |
---|---|
Article number | 2283 |
Journal | Plants |
Volume | 12 |
Issue number | 12 |
DOIs | |
Publication status | Published - Jun 2023 |
Bibliographical note
Publisher Copyright:© 2023 by the authors.
Keywords
- ERK
- allodynia
- magnolin
- neuropathic pain
- paclitaxel
Fingerprint
Dive into the research topics of 'Magnolin Inhibits Paclitaxel-Induced Cold Allodynia and ERK1/2 Activation in Mice'. Together they form a unique fingerprint.Press/Media
-
Researchers at Kyung Hee University Release New Data on Neuropathic Pain (Magnolin Inhibits Paclitaxel-Induced Cold Allodynia and ERK1/2 Activation in Mice)
Park, H.-G., Jang, D. S., Kim, S. K., Kim, K. P. & Cho, I. H.
10/07/23
1 item of Media coverage
Press/Media